Clinical trial
Chemoradiotherapy in Patients With Localised Lung Cancer
NCT00193921 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00193921 |
|---|---|
| Title | Chemoradiotherapy in Patients With Localised Lung Cancer |
| Official title | A Randomised Phase II Study of Two Regimens of Palliative Chemoradiation Therapy in the Management of Locally Advanced Non Small Cell Lung Cancer |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Cancer Council Queensland Victorian Cancer Council |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Carcinoma |
| Intervention type | Drug, Radiation |
| Interventions | Vinorelbine, High dose Radiotherapy, Gemcitabine, Cisplatin, High Dose Radiotherapy |
| Enrollment | 82 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2012 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 4, 2014 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: